| 1 |
to elect, as Class I directors to hold office until the 2028 annual meeting of stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Douglas S. Ingram, Hans Wigzell, M.D., Ph.D., Kathryn J. Boor, Ph.D., Michael Chambers and Deirdre Connelly |
|
| 1.1 |
Election of Douglas S. Ingram as Class I Director |
✗ Against(14)
|
| 1.2 |
Election of Hans Wigzell, M.D., Ph.D. as Class I Director |
✓ For(14)
|
| 1.3 |
Election of Kathryn J. Boor, Ph.D. as Class I Director |
✓ For(14)
|
| 1.4 |
Election of Michael Chambers as Class I Director |
✓ For(14)
|
| 1.5 |
Election of Deirdre Connelly as Class I Director |
✓ For(14)
|
| 2 |
to hold an advisory vote to approve, on a non-binding basis, named executive officer compensation |
✓ For(14)
|
| 3 |
to approve the Company’s 2026 Equity Incentive Plan (the "2026 Plan") |
✗ Against(14)
|
| 4 |
to approve the Company's 2026 Employee Stock Purchase Plan (the "2026 ESPP") |
✓ For(14)
|
| 5 |
to ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the current year ending December 31, 2026 |
✓ For(14)
|
rebel Financial
